Concepts (252)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 1 | 14 | 2022 | 529 | 4.440 |
Why?
|
| Gastrointestinal Microbiome | 6 | 2020 | 122 | 3.200 |
Why?
|
| T-Lymphocytes, Regulatory | 15 | 2022 | 199 | 2.550 |
Why?
|
| Immunoglobulin A | 3 | 2022 | 79 | 2.310 |
Why?
|
| Lupus Erythematosus, Systemic | 5 | 2022 | 756 | 2.270 |
Why?
|
| Autoimmunity | 4 | 2020 | 118 | 2.120 |
Why?
|
| Dendritic Cells | 15 | 2022 | 201 | 2.030 |
Why?
|
| beta-Glucans | 3 | 2020 | 18 | 1.900 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2021 | 114 | 1.660 |
Why?
|
| Mice | 37 | 2022 | 8474 | 1.460 |
Why?
|
| Drinking Water | 3 | 2015 | 33 | 1.440 |
Why?
|
| Gastrointestinal Tract | 3 | 2015 | 63 | 1.430 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2022 | 195 | 1.380 |
Why?
|
| Immune Tolerance | 7 | 2022 | 114 | 1.360 |
Why?
|
| Immunity, Innate | 4 | 2014 | 156 | 1.260 |
Why?
|
| Lectins, C-Type | 4 | 2019 | 39 | 1.220 |
Why?
|
| Antigens, Nuclear | 3 | 2022 | 24 | 1.140 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2020 | 173 | 1.080 |
Why?
|
| Insulin-Secreting Cells | 4 | 2014 | 41 | 1.060 |
Why?
|
| Animals | 38 | 2022 | 20881 | 1.040 |
Why?
|
| Bacteria | 3 | 2020 | 193 | 1.030 |
Why?
|
| Antigens, CD | 7 | 2014 | 230 | 1.020 |
Why?
|
| Centrioles | 2 | 2015 | 7 | 0.970 |
Why?
|
| T-Lymphocytes | 5 | 2019 | 597 | 0.960 |
Why?
|
| Mice, Inbred NOD | 10 | 2021 | 138 | 0.950 |
Why?
|
| Cytokines | 13 | 2015 | 866 | 0.910 |
Why?
|
| Forkhead Transcription Factors | 9 | 2020 | 94 | 0.880 |
Why?
|
| Interleukin-10 | 8 | 2019 | 144 | 0.870 |
Why?
|
| Hyperglycemia | 3 | 2022 | 158 | 0.860 |
Why?
|
| Thyroiditis, Autoimmune | 6 | 2013 | 15 | 0.850 |
Why?
|
| Feces | 5 | 2022 | 88 | 0.840 |
Why?
|
| Cell Cycle Proteins | 2 | 2015 | 230 | 0.830 |
Why?
|
| Gastrins | 1 | 2021 | 27 | 0.810 |
Why?
|
| Colitis | 2 | 2020 | 156 | 0.810 |
Why?
|
| Antigen Presentation | 5 | 2022 | 76 | 0.800 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2014 | 34 | 0.800 |
Why?
|
| Intestinal Mucosa | 2 | 2020 | 219 | 0.790 |
Why?
|
| Transport Vesicles | 1 | 2021 | 5 | 0.780 |
Why?
|
| Polysaccharides | 2 | 2020 | 176 | 0.770 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 87 | 0.760 |
Why?
|
| Lymphocyte Activation | 8 | 2019 | 397 | 0.760 |
Why?
|
| CTLA-4 Antigen | 8 | 2022 | 45 | 0.760 |
Why?
|
| Antigens, Differentiation | 3 | 2007 | 49 | 0.760 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2021 | 63 | 0.750 |
Why?
|
| Microalgae | 1 | 2020 | 5 | 0.730 |
Why?
|
| Glucans | 1 | 2020 | 12 | 0.730 |
Why?
|
| Lysosomes | 1 | 2021 | 136 | 0.730 |
Why?
|
| Bacteroidetes | 1 | 2019 | 5 | 0.660 |
Why?
|
| Phenotype | 2 | 2020 | 947 | 0.660 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2019 | 226 | 0.660 |
Why?
|
| Dietary Carbohydrates | 1 | 2019 | 27 | 0.660 |
Why?
|
| Microbiota | 2 | 2019 | 80 | 0.630 |
Why?
|
| Membrane Proteins | 6 | 2015 | 617 | 0.590 |
Why?
|
| Mice, Inbred C57BL | 6 | 2022 | 2791 | 0.580 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 8 | 2013 | 101 | 0.570 |
Why?
|
| Ligands | 5 | 2022 | 317 | 0.560 |
Why?
|
| Disease Models, Animal | 8 | 2022 | 2550 | 0.550 |
Why?
|
| T-Lymphocyte Subsets | 4 | 2015 | 126 | 0.540 |
Why?
|
| B7-1 Antigen | 2 | 2008 | 20 | 0.530 |
Why?
|
| Fungal Polysaccharides | 1 | 2014 | 3 | 0.490 |
Why?
|
| Disease Progression | 6 | 2020 | 1038 | 0.490 |
Why?
|
| Inflammation | 1 | 2020 | 1030 | 0.460 |
Why?
|
| Lupus Nephritis | 1 | 2015 | 193 | 0.450 |
Why?
|
| Female | 22 | 2022 | 38074 | 0.440 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2011 | 126 | 0.370 |
Why?
|
| Transforming Growth Factor beta | 5 | 2015 | 384 | 0.370 |
Why?
|
| Receptors, Immunologic | 2 | 2022 | 72 | 0.370 |
Why?
|
| Autoantibodies | 4 | 2022 | 434 | 0.360 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2007 | 38 | 0.360 |
Why?
|
| Prebiotics | 2 | 2020 | 10 | 0.350 |
Why?
|
| Receptors, Interleukin-2 | 3 | 2005 | 42 | 0.340 |
Why?
|
| Immunity | 2 | 2020 | 67 | 0.330 |
Why?
|
| Lymphoid Tissue | 2 | 2020 | 30 | 0.310 |
Why?
|
| Signal Transduction | 4 | 2019 | 2689 | 0.300 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 32 | 0.300 |
Why?
|
| HeLa Cells | 2 | 2021 | 237 | 0.300 |
Why?
|
| Mice, Inbred BALB C | 4 | 2020 | 532 | 0.300 |
Why?
|
| Bone Marrow | 2 | 2007 | 168 | 0.300 |
Why?
|
| HEK293 Cells | 2 | 2021 | 326 | 0.290 |
Why?
|
| Thyroglobulin | 4 | 2011 | 17 | 0.290 |
Why?
|
| Green Fluorescent Proteins | 2 | 2020 | 200 | 0.280 |
Why?
|
| Mice, SCID | 4 | 2014 | 238 | 0.280 |
Why?
|
| Membrane Glycoproteins | 2 | 2015 | 370 | 0.280 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 290 | 0.280 |
Why?
|
| Graves Disease | 2 | 2003 | 8 | 0.280 |
Why?
|
| Flow Cytometry | 4 | 2010 | 489 | 0.280 |
Why?
|
| Inflammation Mediators | 2 | 2020 | 244 | 0.270 |
Why?
|
| Biomarkers | 2 | 2022 | 1593 | 0.260 |
Why?
|
| Antigen-Presenting Cells | 3 | 2014 | 50 | 0.260 |
Why?
|
| Age Factors | 2 | 2020 | 1864 | 0.250 |
Why?
|
| Antibodies, Bispecific | 3 | 2014 | 12 | 0.250 |
Why?
|
| Isoantigens | 1 | 2004 | 26 | 0.240 |
Why?
|
| Antibodies, Antinuclear | 2 | 2015 | 171 | 0.240 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2015 | 85 | 0.240 |
Why?
|
| Epitopes | 1 | 2004 | 146 | 0.230 |
Why?
|
| Interleukin-1beta | 3 | 2014 | 88 | 0.230 |
Why?
|
| Humans | 13 | 2022 | 68618 | 0.230 |
Why?
|
| Sex Factors | 2 | 2020 | 1266 | 0.230 |
Why?
|
| Isoenzymes | 2 | 2019 | 308 | 0.220 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2015 | 618 | 0.220 |
Why?
|
| Male | 6 | 2022 | 37321 | 0.220 |
Why?
|
| Immune System | 1 | 2003 | 63 | 0.210 |
Why?
|
| Crosses, Genetic | 2 | 2015 | 60 | 0.210 |
Why?
|
| Zymosan | 2 | 2014 | 12 | 0.210 |
Why?
|
| Permeability | 1 | 2022 | 131 | 0.210 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2022 | 118 | 0.200 |
Why?
|
| Mice, Inbred CBA | 4 | 2007 | 107 | 0.200 |
Why?
|
| Multivesicular Bodies | 1 | 2021 | 3 | 0.200 |
Why?
|
| Down-Regulation | 1 | 2003 | 447 | 0.200 |
Why?
|
| Endosomes | 1 | 2021 | 45 | 0.190 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 507 | 0.190 |
Why?
|
| Endocytosis | 1 | 2021 | 113 | 0.190 |
Why?
|
| Verrucomicrobia | 1 | 2020 | 3 | 0.180 |
Why?
|
| Fatty Acids, Volatile | 1 | 2020 | 8 | 0.180 |
Why?
|
| Protein Transport | 1 | 2021 | 280 | 0.180 |
Why?
|
| Metagenomics | 1 | 2020 | 11 | 0.180 |
Why?
|
| Gene Knock-In Techniques | 1 | 2020 | 35 | 0.180 |
Why?
|
| Metagenome | 1 | 2020 | 17 | 0.180 |
Why?
|
| Dextran Sulfate | 1 | 2020 | 88 | 0.180 |
Why?
|
| ErbB Receptors | 1 | 2021 | 239 | 0.170 |
Why?
|
| Intestines | 1 | 2020 | 114 | 0.170 |
Why?
|
| Cell Line | 4 | 2015 | 1752 | 0.170 |
Why?
|
| Bacteroides fragilis | 1 | 2019 | 20 | 0.170 |
Why?
|
| Antigens | 1 | 2019 | 90 | 0.170 |
Why?
|
| Coculture Techniques | 3 | 2008 | 147 | 0.170 |
Why?
|
| Mice, Knockout | 4 | 2019 | 1692 | 0.170 |
Why?
|
| B7-H1 Antigen | 1 | 2019 | 30 | 0.170 |
Why?
|
| Retinal Dehydrogenase | 1 | 2019 | 10 | 0.170 |
Why?
|
| Up-Regulation | 3 | 2015 | 682 | 0.170 |
Why?
|
| Immunomodulation | 1 | 2019 | 35 | 0.160 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2019 | 87 | 0.160 |
Why?
|
| Mice, Transgenic | 2 | 2014 | 1033 | 0.160 |
Why?
|
| Cell Division | 2 | 2014 | 541 | 0.160 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 1851 | 0.160 |
Why?
|
| Transcriptome | 1 | 2020 | 164 | 0.160 |
Why?
|
| Immunophenotyping | 3 | 2015 | 110 | 0.150 |
Why?
|
| Thymus Gland | 3 | 2008 | 97 | 0.150 |
Why?
|
| Computational Biology | 1 | 2019 | 190 | 0.150 |
Why?
|
| Th17 Cells | 2 | 2015 | 116 | 0.150 |
Why?
|
| Adoptive Transfer | 3 | 2007 | 100 | 0.140 |
Why?
|
| Cells, Cultured | 4 | 2011 | 2673 | 0.130 |
Why?
|
| B7-2 Antigen | 2 | 2008 | 23 | 0.130 |
Why?
|
| Cyanobacteria | 1 | 2015 | 4 | 0.130 |
Why?
|
| Bacteroides | 1 | 2015 | 7 | 0.130 |
Why?
|
| Lactobacillus | 1 | 2015 | 6 | 0.130 |
Why?
|
| Mice, Inbred NZB | 1 | 2015 | 37 | 0.130 |
Why?
|
| Clostridium | 1 | 2015 | 10 | 0.130 |
Why?
|
| Plasma Cells | 1 | 2015 | 19 | 0.130 |
Why?
|
| Leukocyte Common Antigens | 1 | 2015 | 41 | 0.130 |
Why?
|
| Lymphocyte Count | 1 | 2015 | 53 | 0.130 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2015 | 25 | 0.130 |
Why?
|
| Thyroid Gland | 3 | 2005 | 67 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 322 | 0.120 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2015 | 69 | 0.120 |
Why?
|
| 5'-Nucleotidase | 1 | 2014 | 13 | 0.120 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2014 | 31 | 0.120 |
Why?
|
| Proteinuria | 1 | 2015 | 136 | 0.120 |
Why?
|
| Ubiquitination | 1 | 2015 | 85 | 0.120 |
Why?
|
| Cluster Analysis | 1 | 2015 | 219 | 0.120 |
Why?
|
| Proteolysis | 1 | 2015 | 97 | 0.120 |
Why?
|
| Molecular Chaperones | 1 | 2015 | 81 | 0.120 |
Why?
|
| Osteosarcoma | 1 | 2014 | 35 | 0.120 |
Why?
|
| Gene Deletion | 1 | 2015 | 235 | 0.120 |
Why?
|
| RNA, Bacterial | 1 | 2013 | 30 | 0.110 |
Why?
|
| Cloning, Molecular | 1 | 2014 | 357 | 0.110 |
Why?
|
| OX40 Ligand | 1 | 2013 | 7 | 0.110 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2014 | 132 | 0.110 |
Why?
|
| Interleukin-4 | 2 | 2003 | 69 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 1 | 2013 | 114 | 0.110 |
Why?
|
| Phosphoproteins | 1 | 2014 | 202 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 498 | 0.110 |
Why?
|
| Recombinant Proteins | 4 | 2014 | 742 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 146 | 0.100 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 434 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 786 | 0.100 |
Why?
|
| Protein Binding | 1 | 2014 | 1027 | 0.090 |
Why?
|
| Interleukin-2 | 1 | 2011 | 133 | 0.090 |
Why?
|
| Cell Separation | 1 | 2010 | 132 | 0.090 |
Why?
|
| Spleen | 2 | 2007 | 301 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2013 | 753 | 0.080 |
Why?
|
| Hyperinsulinism | 1 | 2008 | 23 | 0.080 |
Why?
|
| Prediabetic State | 1 | 2008 | 48 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2009 | 87 | 0.080 |
Why?
|
| Cell Proliferation | 3 | 2009 | 1174 | 0.080 |
Why?
|
| Lymphopenia | 1 | 2007 | 12 | 0.080 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2007 | 14 | 0.080 |
Why?
|
| Self Tolerance | 2 | 2009 | 8 | 0.080 |
Why?
|
| L-Selectin | 1 | 2007 | 28 | 0.080 |
Why?
|
| Leukodystrophy, Globoid Cell | 1 | 2007 | 27 | 0.070 |
Why?
|
| Aging | 1 | 2013 | 911 | 0.070 |
Why?
|
| Protein Kinase C | 1 | 2008 | 270 | 0.070 |
Why?
|
| Time Factors | 1 | 2015 | 4655 | 0.070 |
Why?
|
| Myasthenia Gravis, Autoimmune, Experimental | 1 | 2006 | 1 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2007 | 163 | 0.070 |
Why?
|
| Pancreas | 1 | 2007 | 225 | 0.070 |
Why?
|
| Antibodies, Blocking | 1 | 2004 | 17 | 0.060 |
Why?
|
| CD4 Antigens | 1 | 2004 | 42 | 0.060 |
Why?
|
| Immunity, Active | 1 | 2003 | 2 | 0.060 |
Why?
|
| Serum | 1 | 2003 | 24 | 0.060 |
Why?
|
| Growth Inhibitors | 1 | 2003 | 33 | 0.060 |
Why?
|
| Neoplasms | 1 | 2014 | 1667 | 0.050 |
Why?
|
| Th2 Cells | 1 | 2003 | 48 | 0.050 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2003 | 100 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2003 | 329 | 0.050 |
Why?
|
| Cricetinae | 2 | 2014 | 262 | 0.040 |
Why?
|
| Interferon-gamma | 2 | 2015 | 241 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 1851 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2014 | 511 | 0.040 |
Why?
|
| Software | 1 | 2019 | 418 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 1046 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2019 | 706 | 0.030 |
Why?
|
| Apyrase | 1 | 2014 | 10 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2014 | 27 | 0.030 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2014 | 2 | 0.030 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2013 | 1 | 0.030 |
Why?
|
| B7 Antigens | 1 | 2013 | 1 | 0.030 |
Why?
|
| Jagged-1 Protein | 1 | 2013 | 3 | 0.030 |
Why?
|
| Receptors, Notch | 1 | 2013 | 15 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2009 | 1034 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 217 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2013 | 525 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 756 | 0.020 |
Why?
|
| CD8 Antigens | 1 | 2009 | 25 | 0.020 |
Why?
|
| CD11c Antigen | 1 | 2009 | 18 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1293 | 0.020 |
Why?
|
| Protein Kinase C-theta | 1 | 2008 | 1 | 0.020 |
Why?
|
| Calcineurin | 1 | 2008 | 13 | 0.020 |
Why?
|
| NFATC Transcription Factors | 1 | 2008 | 40 | 0.020 |
Why?
|
| Age of Onset | 1 | 2009 | 188 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2009 | 75 | 0.020 |
Why?
|
| Galactosylceramidase | 1 | 2007 | 11 | 0.020 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2007 | 23 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2007 | 94 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2008 | 135 | 0.020 |
Why?
|
| Psychosine | 1 | 2007 | 33 | 0.020 |
Why?
|
| Vaccination | 1 | 2009 | 189 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2007 | 124 | 0.020 |
Why?
|
| Receptors, Cholinergic | 1 | 2006 | 30 | 0.020 |
Why?
|
| Axons | 1 | 2007 | 139 | 0.020 |
Why?
|
| Immunization | 1 | 2006 | 86 | 0.020 |
Why?
|
| Cell Communication | 1 | 2006 | 116 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 901 | 0.020 |
Why?
|
| Receptors, Interleukin-10 | 1 | 2005 | 1 | 0.020 |
Why?
|
| Receptors, Interleukin | 1 | 2005 | 22 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2007 | 245 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2006 | 186 | 0.020 |
Why?
|
| Survival Rate | 1 | 2007 | 1056 | 0.020 |
Why?
|
| Receptors, Thyrotropin | 1 | 2003 | 7 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2003 | 89 | 0.010 |
Why?
|
| CHO Cells | 1 | 2003 | 161 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2003 | 101 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 7029 | 0.010 |
Why?
|